19 studies found for:    s1117
Show Display Options
Rank Status Study
1 Active, not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Adult Myelodysplastic Syndrome;   Chronic Myelomonocytic Leukemia;   Chronic Myelomonocytic Leukemia-1;   Chronic Myelomonocytic Leukemia-2;   Previously Treated Myelodysplastic Syndrome;   Refractory Anemia With Excess Blasts
Interventions: Drug: Azacitidine;   Drug: Lenalidomide;   Drug: Vorinostat
2 Completed Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis;   Inflammation
Interventions: Drug: NNC109-0012;   Drug: placebo
3 Completed Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors
Condition: Advance Solid Tumors
Interventions: Drug: Iniparib (SAR240550 - BSI-201);   Drug: Gemcitabine;   Drug: Carboplatin
4 Completed
Has Results
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Condition: Stroke
Interventions: Drug: Aggrenox;   Drug: Clopidogrel placebo;   Drug: Micardis;   Drug: Aggrenox placebo;   Drug: Clopidogrel;   Drug: Micardis placebo
5 Active, not recruiting Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency
Conditions: Congenital Bleeding Disorder;   Congenital FXIII Deficiency
Intervention: Drug: catridecacog
6 Completed Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin aspart;   Drug: insulin human
7 Completed Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin degludec
8 Completed Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin degludec/insulin aspart
9 Completed
Has Results
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children;   Foetal Growth Problem;   Small for Gestational Age;   Genetic Disorder;   Turner Syndrome;   Chronic Kidney Disease;   Chronic Renal Insufficiency;   Delivery Systems
Intervention: Drug: Norditropin NordiFlex®
10 Completed
Has Results
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
Condition: Atrial Fibrillation
Interventions: Drug: dabigatran dose 1;   Drug: dabigatran dose 2
11 Completed Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
Condition: Solid Tumors
Interventions: Drug: SAR245408 (XL147);   Drug: MSC1936369B
12 No longer available An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Condition: HIV Infections
Intervention: Drug: Tipranavir
13 Recruiting Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors
Condition: Malignant Solid Tumors
Intervention: Drug: SAR125844
14 Active, not recruiting Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Condition: Chronic Hepatitis B
Interventions: Drug: TDF;   Drug: PEG
15 Completed A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
16 Recruiting An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738)
Condition: Alzheimer's Disease
Interventions: Drug: MK-8931 (Part I and Part II);   Drug: Placebo (Part I);   Drug: MK-8931 (Part II)
17 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
18 Recruiting A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin 5 mg;   Drug: Ertugliflozin 15 mg;   Drug: Placebo to Ertugliflozin;   Other: Glimepiride;   Drug: Placebo to Glimepiride;   Biological: Basal Insulin;   Drug: Metformin
19 Recruiting Enhancing Written Communication in Persons With Aphasia
Conditions: Aphasia;   Stroke
Interventions: Behavioral: ORLA;   Behavioral: ORLA + Writing

Indicates status has not been verified in more than two years